AQR Capital Management
KRSA

AQR Capital Management’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

AQR Capital Management’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-445
Closed -$191K – 2204
2020
Q4 		$191K Buy
+445
New +$30.3K ﹤0.01% 2095
2020
Q3 		– Sell
-563
Closed -$466K – 2198
2020
Q2 		$466K Sell
563
-600
-52% -$50.2K ﹤0.01% 1768
2020
Q1 		$432K Buy
1,163
+110
+10% +$7.85K ﹤0.01% 1634
2019
Q4 		$401K Buy
+1,053
New +$98.3K ﹤0.01% 1823

Other funds holding KRSA

SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

AQR Capital Management's KRSA Position: Q1 2021 in Review

AQR Capital Management sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q1 2021, closing a stake of 445 shares — an estimated $191K sold.

AQR Capital Management first reported a position in KRSA in Q4 2019 and held it in 4 quarters. The position peaked at $466K in Q2 2020. 69 funds tracked by Wall St. Rank hold KRSA as of Q1 2021.

  • AQR Capital Management reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • AQR Capital Management sold 445 Korsana Biosciences, Inc. Common Stock shares in Q1 2021, an estimated $191K.
  • AQR Capital Management first reported a position in Korsana Biosciences, Inc. Common Stock in Q4 2019 and held it in 4 quarters.
  • AQR Capital Management's Korsana Biosciences, Inc. Common Stock position peaked at $466K in Q2 2020.
  • 69 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q1 2021.

Based on AQR Capital Management's 13F filing for Q1 2021, filed 17 May 2021.